Lilly Backs Sanofi Lawsuit Seeking HRSA 340B Records, Argues Contract Pharmacy Agreements Violate 340B Statute

Eli Lilly has filed an amicus brief in support of Sanofi's lawsuit seeking 340B contract pharmacy agreements from HRSA.
Eli Lilly is backing Sanofi’s lawsuit to compel the federal government to release all 340B contract pharmacy agreements, arguing that [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HHS Appeals Court Ruling That Blocked DSH Calculation Changes That Impact 340B Eligibility

The 5th Circuit Court of Appeals will take up a case that Texas hospitals filed against HHS to block changes to how the Medicare DSH payment calculation is determined.
The Biden Administration has asked a federal appeals court to reconsider a Texas judge’s ruling that voided a Department of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Arkansas, Missouri – Oct 24

Key briefs were filed this week in state contract pharmacy litigation in Arkansas and Missouri.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Kalderos to Resume Legal Battle Over HRSA’s Opposition to Drugmaker 340B Restrictions, Including Rebates

Kalderos will soon file an amended complaint in its case against HRSA before the U.S. District Court for the District of Columbia.
Kalderos, the drug industry vendor behind two 340B claims data submission platforms which support 340B rebates, will file an updated [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Fifth Hospital Sues HRSA for Authorizing ‘Unlawful’ J&J 340B Audits

University of Washington Medical Center sued HRSA for authorizing an allegedly unlawful 340B program audit of the hospital.
A Washington state hospital on Tuesday became the fifth provider to sue the federal government for authorizing Johnson & Johnson [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drugmakers Urge Federal Appeals Court to Dismiss California Health System’s 340B Whistleblower Lawsuit

AbbVie, AstraZeneca, Novartis and Sanofi asked a federal appeals court to dismiss Adventist's 340B whistleblower lawsuit against them.
Four drugmakers are urging a federal appeals court to affirm a lower court’s decision to dismiss a California health system’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Minnesota, Missouri, Mississippi

Key briefs were filed this week in state contract pharmacy litigation in Minnesota, Missouri and Mississippi.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Former J&J Attorney and Current Kalderos Board Director Says Battle over Rebates Has Not Ended

J&J's proposed rebate model was a key topic of discussion at a Wednesday panel led by moderator, 340B Report Publisher and CEO Ted Slafsky.
An influential drug industry expert said that he expects Johnson & Johnson (J&J) to sue the government over its refusal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: New Filings in Missouri, Minnesota

Key motions were recently filed in state contract pharmacy litigation in Missouri and Minnesota.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Health Centers Urge Federal Appeals Court to Take Their Side in Case Alleging Drug Manufacturer Collusion on Contract Pharmacy Restrictions

Two community health centers argued in a Sept. 30 filing with the U.S. 2nd Circuit Court of Appeals that diabetes drugmakers colluded to place contract pharmacy restrictions.
Two community health centers urged a federal appeals court to overturn the dismissal of their 340B antitrust lawsuit, arguing in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live